Friday, 11 April 2008

Ghost management must stop

The drug industry manages trials, analyses data, has papers written, finds academic ghost authors, and pays communication companies to get published in the best journals, says Sergio Sismondo in PloS Medicine. All this leads to bias that influences medical practice and ultimately affects patients. Universities should prohibit contracts that allow sponsors to draft, edit, or suppress articles or that allow sponsors to keep data from authors. They should even prohibit sponsors from facilitating publication and should also take disciplinary action against investigators who serve as authors on ghost managed articles, he says. (PLoS Med 4(9):e286; doi: 10.1371/journal.pmed.0040286)

No comments: